An oral GLP-1/amylin agonist named oral amycretin (Novo Nordisk) is also in phase 1 development
Circulation, 138 (25), 29082918
CONCERN #2: SLOW MUSCLE RECOVERY AND PERSISTENT SORENESS Description: You push yourself in a workout, but instead of bouncing back in a day or two, you're still sore, stiff, and weak a week later
Central to this process is the Nuclear Factor Erythroid 2Related Factor 2 (Nrf2)-ARE signaling pathway, which significantly enhances the activity of key antioxidant enzymes
We did not include pediatric patients or geriatric patients older than 70 years, and our cohort was fairly demographically homogeneous, so it is unclear whether our findings are generalizable to various groups
GLP-1 receptor agonists like Ozempic (Semaglutide), Mounjaro (Tirzepatide), and Wegovy have revolutionized medical weight loss